Jeffrey Jaime, CISSPServant Leader & CEO Driving AI Innovation and Team Excellence

Anti-Aging Regenerative Doctor, Joy Kong, and the Stem Cell Industry

29 Nov 2024 · 1 min

Watch on YouTube

0:59

This is an interview-style conversation with Dr. Joy Kong, who describes herself as an "ex-psychiatrist turned anti-aging doctor" specializing in regenerative medicine and stem cell therapy. She says she is board-certified in psychiatry, addiction medicine, and anti-aging/regenerative medicine, expresses strong enthusiasm for stem cell potential, and notes an industry-level claim that bringing a molecule from discovery to market costs about $2.1 billion, citing financial strain on tissue banks and FDA regulatory burdens.

Chapters

Joy, how you describe yourself to people. Regenerative medicine physician. Like, if I'm sitting next to you on an airplane, how do you introduce yourself?
Like an ex psychiatrist turned into anti aging doctor, specializing in stem cell therapy. So I'm board certified in three specialties. Psychiatry, addiction medicine, and anti aging. Regenerative medicine. But ever since I got introduced to stem cell therapy, that was like, it's like someone opened up a whole new world for you. I was just blown away by the potentials of these cells in general. Just so you know, on average, to take any molecule, any discovery, from discovery to market, that process costs about $2.1 billion. And nobody has that kind of money unless you're a big drug company. Just so you're aware, and I've heard already, of tissue banks going bankrupt trying to do these studies. The FDA is requiring.